Thu, September 3, 2020
Wed, September 2, 2020
Tue, September 1, 2020

Nathan Weinstein Downgraded (ACST) to Hold and Decreased Target to $12 on, Sep 2nd, 2020

Nathan Weinstein of Aegis Capital, Downgraded "Acasti Pharma Inc." (ACST) to Hold and Decreased Target from $103 to $12 on, Sep 2nd, 2020.

Nathan has made no other calls on ACST in the last 4 months.



There are 3 other peers that have a rating on ACST. Out of the 3 peers that are also analyzing ACST, 2 agree with Nathan's Rating of Hold. Following are those relevant analyst calls for the last 4 months


  • Leland Gershell of "Oppenheimer" Downgraded from Buy to Hold on, Tuesday, September 1st, 2020
  • Mike Crawford of "B. Riley Securities" Downgraded from Strong Buy to Hold and Decreased Target to $24 on, Tuesday, September 1st, 2020


This is the rating of the analyst that currently disagrees with Nathan


  • Mayank Mamtani of "B. Riley Securities" Upgraded from Hold to Strong Buy and Held Target at $96 on, Monday, July 6th, 2020